Vaccines—the silent protectors

Vaccines have revolutionized the control of virus-borne communicable diseases, from polio to COVID-19 to hepatitis A. Modern vaccine production is moving from egg-based to virus-like particles and RNA constructs. YMC enables these new platforms with proven technologies, from our YMC-Triart C18 silica to the industry’s most advanced continuous purification systems based on the patented MCSGP process.

Whether a vaccine is synthesized or cultured, YMC can address its purification needs with:

  • TFF membrane systems
  • Batch or continuous LPLC and HPLC chromatography systems
  • Pre-packed columns
  • Bulk column packing materials: RP, IEX, NP, SEC, HIC, Chiral, and more
  • Glass and SS (DAC) empty columns
  • Bench-top FPLC systems
  • Custom process skids for most downstream unit operations

More Resources Related to This Topic

Application Search

Use our extensive Applications Search page to mine a dynamically growing collection of over 350 YMC-produced application notes.

The data can be searched by any combination of several variables, including sample classification, compound name (including partial names), and column parameters.

Contact YMC America

For more information on products and services from YMC, YMC ChromaCon, or just to say hello, get in touch with us by clicking on the button below.